Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,464 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03942068 | Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 35 | Henan Cancer HospitalOTHER_GOV | 0 | May 8, 2019 | clinicaltrials |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03924882 |
| Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer |
| unknown |
| Phase 2 |
| 30 |
| Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER |
| 1 |
| Apr 23, 2019 |
| clinicaltrials |
| NCT03489473 | FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment(FESPET) | unknown | — | 40 | Radboud University Medical CenterOTHER | 0 | Apr 18, 2019 | clinicaltrials |
| NCT02349958 | Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy(HIPEC/IPHC) | unknown | Phase 2 | 200 | Bay Area Gynecology OncologyOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03916679 | MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer | unknown | Phase 1 / Phase 2 | 20 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03799913 | MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | unknown | Early Phase 1 | 20 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03904368 | The Value of Myomectomy in Women With Intramural Myoma Before IVF. | unknown | N/A | 100 | Cairo UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03412526 | Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian | unknown | Phase 2 | 15 | Sheba Medical CenterOTHER_GOV | 1 | Apr 4, 2019 | clinicaltrials |
| NCT03846856 | The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance | unknown | — | 40 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Apr 4, 2019 | clinicaltrials |
| NCT03895788 | A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer | unknown | Phase 1 | 24 | Hunan Cancer HospitalOTHER | 1 | Mar 29, 2019 | clinicaltrials |
| NCT03150992 | EDMONd - Elemental Diet in Bowel Obstruction(EDMONd) | unknown | N/A | 34 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT00006903 | Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer | unknown | Phase 2 | 67 | Gynecologic Oncology GroupNETWORK | 0 | Mar 20, 2019 | clinicaltrials |
| NCT00807768 | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer | unknown | Phase 3 | 601 | Gynecologic Oncology GroupNETWORK | 2 | Mar 20, 2019 | clinicaltrials |
| NCT00958698 | Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | unknown | N/A | 485 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT01295502 | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer | unknown | Phase 1 | 45 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT01372787 | Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | unknown | — | 103 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT01561586 | Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer(TACO) | unknown | Phase 3 | 374 | Korea Cancer Center HospitalOTHER | 4 | Feb 27, 2019 | clinicaltrials |
| NCT03818282 | Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer(OC-01) | unknown | Phase 2 | 77 | Huazhong University of Science and TechnologyOTHER | 0 | Feb 26, 2019 | clinicaltrials |
| NCT03792009 | Paracervical Block in Laparoscopic Hysterectomy(PALAPA) | unknown | N/A | 86 | Kangbuk Samsung HospitalOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03838055 | Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease | unknown | N/A | 362 | Region SkaneOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03692637 | Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer | unknown | Early Phase 1 | 30 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03459976 | HE4 is a Beneficial Biomarker in Endometrial Cancer(HE4) | unknown | — | 87 | Ain Shams UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03813576 | Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study | unknown | N/A | 300 | National University Hospital, SingaporeOTHER | 0 | Jan 23, 2019 | clinicaltrials |
| NCT03559803 | A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer | unknown | N/A | 58 | Sichuan UniversityOTHER | 1 | Jan 22, 2019 | clinicaltrials |
| NCT03808792 | Imaging Study in Advanced Ovarian Cancer(ISAAC) | unknown | — | 400 | Charles University, Czech RepublicOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT03804463 | The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer | unknown | N/A | 170 | Min WangOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT03793205 | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients | unknown | Phase 4 | 100 | Lei LiOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT03178136 | HR-HPV Multi-site Opportunistic Screening in Liaoning, China | unknown | — | 10,000 | Min WangOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03188744 | Impact of Cancer Treatment on the Pelvic Floor Function in Survivors of Cervical Cancer | unknown | — | 150 | University of Sao PauloOTHER | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03553589 | Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma(BioEndoCar) | unknown | — | 400 | Andrea RomanoOTHER | 3 | Dec 5, 2018 | clinicaltrials |
| NCT03763123 | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. | unknown | Phase 1 | 48 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 4, 2018 | clinicaltrials |
| NCT03740672 | Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline | unknown | — | 1,000 | Lei LiOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03744962 | MSI in Circulatory DNA of Endometrial Cancer | unknown | — | 100 | Lei LiOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03742388 | A Genomic Analysis of Evolution of Epithelia Ovarian Tumors | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03742856 | A Multi-omics Study of Epithelial Ovarian Cancer | unknown | — | 80 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03742869 | HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03738319 | Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer | unknown | — | 160 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03740464 | Long-acting G-CSF for Febrile Neutropenia | unknown | Phase 3 | 556 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03110497 | Single Application Brachytherapy in Cervical Cancer | unknown | N/A | 40 | Tata Memorial HospitalOTHER_GOV | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | unknown | N/A | 9,800 | Western Health and Social Care TrustOTHER | 1 | Oct 26, 2018 | clinicaltrials |
| NCT02480790 | Venous Thromboembolic Complications in Ovarian Cancer | unknown | — | 98 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Oct 5, 2018 | clinicaltrials |
| NCT03252769 | Vaginal Self-sampling for Non-attenders | unknown | N/A | 1,950 | Western Health and Social Care TrustOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT02667431 | Cancer of the Uterus and Treatment of Stress Urinary Incontinence(CUTI) | unknown | — | 556 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03659110 | Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice | unknown | — | 1,000 | Beijing Chaoyang District Centre for Disease Control and PreventionOTHER | 0 | Sep 27, 2018 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2019source: clinicaltrials